Member Login
  1. Stocks
    2. /
  2. AbbVie Inc. (NYSE: ABBV)
    3. /

NYSE:ABBV (AbbVie Inc.)

About ABBV

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. The company's primary product is Humira, administered via injection.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AbbVie Inc. (NYSE: ABBV) Latest News

The flag of the United States of America flying in front of the Capitol building
Investing Articles

2 great dividend shares I’m buying now

| Muhammad Cheema

AbbVie and US Bancorp are two dividend shares that have plunged recently. Let’s take a deeper dive below to see…

Read more »

Investing Articles

3 pharma stocks to watch in April

| Pam Narang

Pharma stocks are rarely a bad bet in the long term, but risk can vary widely and should be weighed…

Read more »

Investing Articles

Should I Invest In Direct Line Insurance Group PLC, Mountview Estates plc And Shire PLC Now?

| Kevin Godbold

Can Direct Line Insurance Group PLC (LON: DLG), Mountview Estates plc (LON: MTVW) and Shire PLC (LON: SHP) still deliver…

Read more »

Investing Articles

Is Shire PLC A Buy After AbbVie Inc Withdraws Takeover Offer?

| Roland Head

Shire PLC (LON:SHP) is starting to look attractive again, now that the AbbVie Inc (NYSE:ABBV) deal is over.

Read more »

Investing Videos

A Closer Look At Shire PLC

| Nate Weisshaar

VIDEO: Two Fools take a closer look at Shire PLC (LON:SHP).

Read more »

Investing Articles

Why AbbVie Inc Is Buying Shire PLC

| Prabhat Sakya

AbbVie Inc (NYSE:ABBV) and Shire PLC (LON:SHP) have strongly complementary research portfolios.

Read more »

Company Comment

Shire PLC Accepts £32bn Takeover By AbbVie Inc

| Sam Robson

Shire PLC (LON:SHP) agrees to £32bn AbbVie Inc (NYSE: ABBV) deal.

Read more »

Investing Articles

One Reason Why AstraZeneca plc Is A Risky Bet

| Alessandro Pasetti

It's tough for AstraZeneca plc (LON:AZN) shareholders, argues Alessandro Pasetti.

Read more »

Company Comment

Shire PLC Willing To Recommend £32bn Bid From AbbVie Inc

| Mark Stones

There's a Friday deadline for AbbVie Inc (NYSE: ABBV) to decide whether to make firm offer for Shire PLC (LON:…

Read more »

Investing Articles

AbbVie Inc’s Raised Bid Confirms My Shire PLC Sell Rating

| Roland Head

Shire PLC (LON:SHP) shares are sliding following AbbVie Inc (NYSE: ABBV)'s increased bid, confirming this Fool's previous sell call.

Read more »

Investing Articles

AbbVie Will Make Another Attempt To Buy Shire PLC

| Rupert Hargreaves

AbbVie iNC (NYSE:ABBV) is likely to make another bid for Shire PLC (LON: SHP).

Read more »